An examination of the relationship between non-depression-related costs and uninterrupted Tx

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Depression is an important disease for many managed care organizations and can be one of the largest cost drivers in their drug budget. A number of studies have focused on the cost impact of anti-depressant treatment. One previously published study showed that significant savings in office-based service costs was likely in patients who completed at least 6 months of antidepressant therapy. The purpose of this study was to determine if these results could be replicated in another managed care population. The methodology from the previously published study was adopted as a framework for this analysis. No analyses in the current study demonstrated that uninterrupted antidepressant treatment was associated with a large reduction in non-depression-related costs.

Original languageEnglish (US)
Pages (from-to)461-468
Number of pages8
JournalFormulary
Volume36
Issue number6
StatePublished - 2001

Fingerprint

Costs and Cost Analysis
Managed Care Programs
Antidepressive Agents
Budgets
Therapeutics
Organizations
Pharmaceutical Preparations
Population

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

An examination of the relationship between non-depression-related costs and uninterrupted Tx. / Armstrong, Edward P; Abarca, J.

In: Formulary, Vol. 36, No. 6, 2001, p. 461-468.

Research output: Contribution to journalArticle

@article{05ce1d856f9e498888181b990dc5923b,
title = "An examination of the relationship between non-depression-related costs and uninterrupted Tx",
abstract = "Depression is an important disease for many managed care organizations and can be one of the largest cost drivers in their drug budget. A number of studies have focused on the cost impact of anti-depressant treatment. One previously published study showed that significant savings in office-based service costs was likely in patients who completed at least 6 months of antidepressant therapy. The purpose of this study was to determine if these results could be replicated in another managed care population. The methodology from the previously published study was adopted as a framework for this analysis. No analyses in the current study demonstrated that uninterrupted antidepressant treatment was associated with a large reduction in non-depression-related costs.",
author = "Armstrong, {Edward P} and J. Abarca",
year = "2001",
language = "English (US)",
volume = "36",
pages = "461--468",
journal = "Formulary",
issn = "1082-801X",
publisher = "Advanstar Communications",
number = "6",

}

TY - JOUR

T1 - An examination of the relationship between non-depression-related costs and uninterrupted Tx

AU - Armstrong, Edward P

AU - Abarca, J.

PY - 2001

Y1 - 2001

N2 - Depression is an important disease for many managed care organizations and can be one of the largest cost drivers in their drug budget. A number of studies have focused on the cost impact of anti-depressant treatment. One previously published study showed that significant savings in office-based service costs was likely in patients who completed at least 6 months of antidepressant therapy. The purpose of this study was to determine if these results could be replicated in another managed care population. The methodology from the previously published study was adopted as a framework for this analysis. No analyses in the current study demonstrated that uninterrupted antidepressant treatment was associated with a large reduction in non-depression-related costs.

AB - Depression is an important disease for many managed care organizations and can be one of the largest cost drivers in their drug budget. A number of studies have focused on the cost impact of anti-depressant treatment. One previously published study showed that significant savings in office-based service costs was likely in patients who completed at least 6 months of antidepressant therapy. The purpose of this study was to determine if these results could be replicated in another managed care population. The methodology from the previously published study was adopted as a framework for this analysis. No analyses in the current study demonstrated that uninterrupted antidepressant treatment was associated with a large reduction in non-depression-related costs.

UR - http://www.scopus.com/inward/record.url?scp=0034965422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034965422&partnerID=8YFLogxK

M3 - Article

VL - 36

SP - 461

EP - 468

JO - Formulary

JF - Formulary

SN - 1082-801X

IS - 6

ER -